Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Hodgkin Disease 65Lymphoma 39Urinary Bladder Neoplasms 16Carcinoma, Non-Small-Cell Lung 11Melanoma 9Lung Neoplasms 9Urethral Neoplasms 4Recurrence 4Prostatic Neoplasms 4Lymphoma, Large-Cell, Anaplastic 4Testicular Neoplasms 3Neoplasms 3Leukemia 3Glioma 3Central Nervous System Neoplasms 3Astrocytoma 3Testicular Germ Cell Tumor 2Teratoma 2Skin Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Kidney Neoplasms 2HIV Infections 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Ureteral Neoplasms 1Survival Without Progression 1

Interventions

Cisplatin 55Carboplatin 50pembrolizumab 42Paclitaxel 42Gemcitabine 28Pemetrexed 23Radiotherapy 21Magnetic Resonance Spectroscopy 20Radiotherapy, Intensity-Modulated 18Cetuximab 18Docetaxel 17Specimen Handling 16Nivolumab 16Fluorouracil 16Cyclophosphamide 14durvalumab 13Bevacizumab 13Sorafenib 12Radiation 11130-nm albumin-bound paclitaxel 11Sunitinib 10Platinum 101,2-diaminocyclohexaneplatinum II citrate 10osimertinib 9Oxaliplatin 8Irinotecan 8Ipilimumab 8Everolimus 8Drug Therapy 8Capecitabine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Vinblastine × Clear all
NCT02412670 2023-07-10

Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
36 enrolled 14 charts
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡